These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 21386708
21. Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure. Sabbah HN, Imai M, Cowart D, Amato A, Carminati P, Gheorghiade M. Am J Cardiol; 2007 Jan 22; 99(2A):41A-46A. PubMed ID: 17239704 [Abstract] [Full Text] [Related]
22. Levosimendan in two neonates with ischemic heart failure and pulmonary hypertension. De Carolis MP, Piastra M, Bersani I, Pardeo M, Stival E, Tempera A, Romagnoli C, Conti G, De Rosa G. Neonatology; 2012 Jan 22; 101(3):201-5. PubMed ID: 22067520 [Abstract] [Full Text] [Related]
23. Levosimendan: current status and future prospects. Archan S, Toller W. Curr Opin Anaesthesiol; 2008 Feb 22; 21(1):78-84. PubMed ID: 18195615 [Abstract] [Full Text] [Related]
24. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ. Crit Care Med; 2007 Jan 22; 35(1):252-9. PubMed ID: 17133188 [Abstract] [Full Text] [Related]
29. Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure. Sandell EP, Hayha M, Antila S, Heikkinen P, Ottoila P, Lehtonen LA, Pentikainen PJ. J Cardiovasc Pharmacol; 1995 Jan 22; 26 Suppl 1():S57-62. PubMed ID: 8907132 [Abstract] [Full Text] [Related]
30. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Blair JE, Macarie C, Ruzyllo W, Bacchieri A, Valentini G, Bianchetti M, Pang PS, Harinstein ME, Sabbah HN, Filippatos GS, Gheorghiade M, HORIZON-HF investigators. Am J Ther; 2008 Jan 22; 15(3):231-40. PubMed ID: 18496261 [Abstract] [Full Text] [Related]
31. Levosimendan and pulmonary hypertension. Cavusoglu Y, Beyaztas A, Birdane A, Ata N. J Cardiovasc Med (Hagerstown); 2010 Jul 22; 11(7):478-80. PubMed ID: 20516805 [No Abstract] [Full Text] [Related]
32. Evidence-based use of levosimendan in different clinical settings. De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. Eur Heart J; 2006 Aug 22; 27(16):1908-20. PubMed ID: 16682381 [Abstract] [Full Text] [Related]